News

The study designed to assess the investigational drug AXL1717 in patients with relapsed or progressive malignant astrocytomas (glioblastoma and anaplastic astrocytoma) is conducted at the Rush University Medical

POD that facilitates a cleanroom space of 768ft² in addition to a partial ceiling height of 15′ is designed to preserve relative humidity at 35% in a controlled

The collaboration will focus on developing a system based on Quantum Cascade Laser (QCL) infrared spectroscopy for the noncontact cleaning verification of vessels throughout the manufacturing process. The

The new patent provides protection for the company’s universal flu vaccine target, M2e, which is a viral peptide common in all flu strains. Augmenta founder, president and CSO

The energy supplement that is free from fat contains no related caffeine or sugar thereby avoiding unwanted side effects, according to the company. Essential Edibles founder and CEO

The bosutinib positive CHMP opinion is concerned with the conditional marketing authorization in the European Union for the treatment of different phases of philadelphia chromosome positive chronic myelogenous

Phase 1 trial, being conducted in the US, Canada and Denmark, will assess the most favorable KPT-330 dose to treat advanced hematologic malignancies. Karyopharm founder, chief scientific officer

The technology will be evaluated in refolding difficult to express microbial products that are expressed as inclusion bodies, under the agreement. BaroFold CSO and Founder Matthew Seefeldt said,

The acquisition aims to provide better quality diagnostic services to community patients in British Columbia, Canada, through patient service centers, homecare and long-term care visits, and dedicated laboratory